Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Non-Current Deferred Tax Liability came in at $2.0 million in Q2 2026, up 2003.16% year-over-year from $95000.0 in Q2 2025, and up 7.71% quarter-over-quarter from $1.9 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 2003.16% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $2.0 million, a 2003.16% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 1941.18% from the prior year.
  • Non-Current Deferred Tax Liability was $2.0 million for Q2 2026 at Lemaitre Vascular, up from $1.9 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $2.1 million in Q3 2025 and troughed at $60000.0 in Q3 2022.
  • A 5-year average of $491722.2 and a median of $91500.0 in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability slumped 50.82% in 2022 and surged 2007.95% in 2026, its largest moves.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $69000.0 in 2022, then jumped by 55.07% to $107000.0 in 2023, then dropped by 20.56% to $85000.0 in 2024, then jumped by 1941.18% to $1.7 million in 2025, then gained by 15.16% to $2.0 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $2.0 million (Q2 2026), $1.9 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Mn
Mar 31, 2026 1.86 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 2.09 Mn
Jun 30, 2025 95,000.00
Mar 31, 2025 88,000.00
Dec 31, 2024 85,000.00
Sep 30, 2024 109,000.00
Jun 30, 2024 104,000.00
Mar 31, 2024 114,000.00
Dec 31, 2023 107,000.00
Sep 30, 2023 69,000.00
Jun 30, 2023 72,000.00
Mar 31, 2023 71,000.00
Dec 31, 2022 69,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 64,000.00
Mar 31, 2022 68,000.00
Dec 31, 2021 70,000.00
Sep 30, 2021 122,000.00